FDA warned Anna Health that website claims made its supplements unapproved drugs, including Immune Health for COVID-19.
What happened
From October 2020 to March 2021, FDA reviewed www.annahealth.com and found it took orders for Fucoidan, Prostate Health, Children Liquid Vitamins, and Immune Health. The site claimed these products treated cancer, enlarged prostate, anemia, anxiety, and COVID-19, among other conditions. FDA said the claims make the products unapproved new drugs and misbranded because their directions are not adequate for safe lay use.
What FDA found
Website claims show Fucoidan, Prostate Health, Children Liquid Vitamins, and Immune Health are intended to treat disease.
section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 321(g)(1)(B)]The products are unapproved new drugs, meaning products that need FDA approval before sale, because FDA has not found them safe and effective for those uses.
sections 301(d) and 505(a) [21 U.S.C. 331(d), 355(a)]The products are misbranded because they lack adequate directions for safe use by a layperson for diseases that need a licensed practitioner.
section 502(f)(1) [21 U.S.C. 352(f)(1)]; 21 CFR 201.5The misbranded products were introduced or delivered for introduction into interstate commerce.
section 301(a) [21 U.S.C. 331(a)]
What FDA wants
FDA asks Anna Health to take immediate action to stop selling any unapproved or unauthorized products claimed for COVID-19. It also asks the company to notify FDA in writing within 15 working days of steps taken to fix violations, or explain any delay and set a completion time.
Who should pay attention
- online sellers of dietary supplements
- retailers and brands selling immune or prostate products
- companies making disease-treatment claims on product websites
This is a summary. Read the original letter on fda.gov.